Previsioni di mercato delle malattie renali in Nord America fino al 2027: impatto del COVID-19 e analisi regionale per prodotto (diagnosi e trattamento); Utente finale (ospedali, laboratori diagnostici e altri); e Paese
La malattia renale è anche nota come malattia renale. È causato dal malfunzionamento del rene. Esistono vari tipi di malattie renali tra cui calcoli renali, glomerulonefrite, infezioni del tratto urinario e altre. Per il trattamento e la diagnosi di questi tipi di malattie, diversi attori globali e regionali offrono vari prodotti e servizi.
Panoramica e dinamiche del mercato< /u>
Il mercato delle malattie renali in Nord America dovrebbe raggiungere i 42.462,1 milioni di dollari nel 2027 dai 25.483,5 milioni di dollari nel 2019. Si stima che il mercato crescerà con un CAGR del 6,7% a partire dal 2020 -2027. La crescita del mercato è attribuita ad alcuni fattori chiave come la crescente prevalenza di malattie croniche legate ai reni e l’elevata crescita dell’invecchiamento della popolazione. Tuttavia, si prevede che il mercato registrerà una crescita lenta durante il periodo di previsione a causa del fallimento nella diagnosi dei casi di malattie renali.
Segmenti chiave del mercato
In base al prodotto, il mercato delle malattie renali è segmentato per la diagnosi e il trattamento. Il segmento diagnostico è ulteriormente suddiviso in esami del sangue, esami delle urine, test di imaging e altri. Il segmento del trattamento è ulteriormente suddiviso in dialisi, classe di farmaci e altri. La classe di farmaci è suddivisa in ACE inibitori, bloccanti del recettore dell\'angiotensina-2, diuretici e altri. In base all\'utente finale, il mercato delle malattie renali è segmentato in ospedali, laboratori diagnostici e altri.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie del mercato delle malattie renali incluse nel rapporto sono American Urological Association, National Kidney Foundation,Kidney International Report,< span> e altri.
< /strong>
Motivi per acquistare il rapporto
Comprendere il panorama del mercato della malattia renale in Nord America e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno
Stare al passo con i tempi gareggia comprendendo il panorama competitivo in continua evoluzione del mercato delle malattie renali
Pianifica in modo efficiente fusioni, acquisizioni e accordi di partnership nel mercato delle malattie renali del Nord America identificando i segmenti di mercato con le vendite probabili più promettenti< /li>
Aiuta a prendere decisioni aziendali consapevoli grazie a un\'analisi perspicace e completa delle prestazioni di mercato dei vari segmenti del mercato delle malattie renali
Ottenere previsioni sulle entrate del mercato per il mercato in base a vari segmenti dal 2019 al 2027 nella regione del Nord America
SEGMENTAZIONE DEL MERCATO DELLA MALATTIA RENALE DEL NORD AMERICA
Per prodotto
·Diagnosi
oEsami del sangue
oEsami delle urine
oTest di imaging
oAltri
·Trattamento
oDialisi
oAltri
oClasse sui farmaci
§ACE-inibitori
§Bloccanti del recettore dell\'angiotensina II
§Diuretici
§Altro
Per utente finale
·   ; Ospedali
·Laboratori diagnostici
·Altro
Per Paese
·Nord America
oStati Uniti
oCanada
oMessico
Profili aziendali
Abbott
F. Hoffmann-La Roche Ltd
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc.
Amgen Inc.
Sysmex Corporation
< li class=\"MsoNormalCxSpMiddle\">Siemens AG
North America Kidney Disease Strategic Insights
Strategic insights for North America Kidney Disease involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
North America Kidney Disease Report Scope
Report Attribute
Details
Market size in 2019
US$ 25,483.5 Million
Market Size by 2027
US$ 42,462.1 Million
Global CAGR (2020 - 2027)
6.7%
Historical Data
2017-2018
Forecast period
2020-2027
Segments Covered
By Prodotto
Diagnosi e Trattamento
By Utente finale
ospedali
laboratori diagnostici
Regions and Countries Covered
Nord America
Stati Uniti
Canada
Messico
Market leaders and key company profiles
Abbott
F. Hoffmann-La Roche Ltd
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc.
Amgen Inc.
Sysmex Corporation
Siemens AG
Get more information on this report
North America Kidney Disease Regional Insights
The regional scope of North America Kidney Disease refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - North America Kidney Disease Market
The List of Companies - North America Kidney Disease Market
Abbott
F. Hoffmann-La Roche Ltd
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc.
Amgen Inc.
Sysmex Corporation
Siemens AG
Frequently Asked Questions
How big is the North America Kidney Disease Market?
The North America Kidney Disease Market is valued at US$ 25,483.5 Million in 2019, it is projected to reach US$ 42,462.1 Million by 2027.
What is the CAGR for North America Kidney Disease Market by (2020 - 2027)?
As per our report North America Kidney Disease Market, the market size is valued at US$ 25,483.5 Million in 2019, projecting it to reach US$ 42,462.1 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.
What segments are covered in this report?
The North America Kidney Disease Market report typically cover these key segments-
Prodotto (Diagnosi e Trattamento)
Utente finale (ospedali, laboratori diagnostici)
What is the historic period, base year, and forecast period taken for North America Kidney Disease Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Kidney Disease Market report:
Historic Period : 2017-2018
Base Year : 2019
Forecast Period : 2020-2027
Who are the major players in North America Kidney Disease Market?
The North America Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Abbott
F. Hoffmann-La Roche Ltd
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc.
Amgen Inc.
Sysmex Corporation
Siemens AG
Who should buy this report?
The North America Kidney Disease Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the North America Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For North America Kidney Disease Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines